Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Manufacturers Notice of Registration - 2019 > Siemens Healthcare Diagnostics, Inc.

Manufacturers Notice of Registration - 2019

[Federal Register Volume 84, Number 190 (Tuesday, October 1, 2019)]
[Notices]
[Page 52135]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-21313]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]

Bulk Manufacturer of Controlled Substances Registration; Siemens Healthcare Diagnostics, Inc.

ACTION: Notice of registration.


SUMMARY: The registrants listed below have applied for and been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule I and II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as a bulk manufacturer of a basic class of schedule I and II controlled substances. Information on previously published notices is listed below. No comments or objections were submitted for the notice.

Company FR Docket Published
Siegfried USA, LLC 84 FR 7129 March 1, 2019
Patheon Pharmaceuticals, Inc 84 FR 8114 March 6, 2019
S & B Pharma Inc 84 FR 8116 March 6, 2019
Siemens Healthcare Diagnostics, Inc 84 FR 10534 March 21, 2019
Synthcon, LLC 84 FR 13962 April 8, 2019

The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each of the company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed companies.

Dated: September 23, 2019.

Thomas W. Prevoznik,
Acting Assistant Administrator, Deputy Assistant Administrator.

[FR Doc. 2019-21313 Filed 9-30-19; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility